166 related articles for article (PubMed ID: 2578874)
1. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo.
Cupo DY; Wetterhahn KE
Cancer Res; 1985 Mar; 45(3):1146-51. PubMed ID: 2578874
[TBL] [Abstract][Full Text] [Related]
2. Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung.
Tsapakos MJ; Hampton TH; Wetterhahn KE
Cancer Res; 1983 Dec; 43(12 Pt 1):5662-7. PubMed ID: 6640521
[TBL] [Abstract][Full Text] [Related]
3. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
[TBL] [Abstract][Full Text] [Related]
4. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
Ueno S; Susa N; Furukawa Y; Sugiyama M
Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823
[TBL] [Abstract][Full Text] [Related]
5. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds.
Dartsch PC; Hildenbrand S; Kimmel R; Schmahl FW
Int Arch Occup Environ Health; 1998 Sep; 71 Suppl():S40-5. PubMed ID: 9827879
[TBL] [Abstract][Full Text] [Related]
6. Biliary and gastrointestinal excretion of chromium after administration of Cr-III and Cr-VI in rats.
Manzo L; Di Nucci A; Edel J; Gregotti C; Sabbioni E
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):113-25. PubMed ID: 6648036
[TBL] [Abstract][Full Text] [Related]
7. [Role of supranucleosomal structures of chromatin in the uneven distribution of DNA-bound 7,12-dimethylbenz(a)anthracene metabolites formed in vivo or in the perfused rat liver].
Chekulaev VA; Lobanenkov VV; Karamysheva AF; Shelepov VP; Mironov NM
Biokhimiia; 1984 Sep; 49(9):1515-22. PubMed ID: 6440596
[TBL] [Abstract][Full Text] [Related]
8. Induction of lipid peroxidation in mice by hexavalent chromium and its relation to the toxicity.
Susa N; Ueno S; Furukawa Y; Michiba N; Minoura S
Nihon Juigaku Zasshi; 1989 Dec; 51(6):1103-10. PubMed ID: 2601225
[TBL] [Abstract][Full Text] [Related]
9. Evidence of DNA binding activity of perchloroethylene.
Mazzullo M; Grilli S; Lattanzi G; Prodi G; Turina MP; Colacci A
Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):215-35. PubMed ID: 2447621
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the binding of N-2-fluorenylacetamide to specific regions of the hepatic genome in vivo in rats.
Schwartz EL; Braselton WE; Goodman JI
J Natl Cancer Inst; 1981 Apr; 66(4):667-72. PubMed ID: 6939914
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats.
Glaser U; Hochrainer D; Klöppel H; Oldiges H
Toxicology; 1986 Dec; 42(2-3):219-32. PubMed ID: 3798470
[TBL] [Abstract][Full Text] [Related]
12. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats.
Bagchi D; Hassoun EA; Bagchi M; Stohs SJ
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Feb; 110(2):177-87. PubMed ID: 7599967
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the state of hormone-receptor complexes which contain specific binding sites of rat liver chromatin particles as affected by cortisol].
Kuz'menko AP
Biokhimiia; 1984 Oct; 49(10):1634-9. PubMed ID: 6518184
[TBL] [Abstract][Full Text] [Related]
14. Biliary excretion of chromium in the rat: a role of glutathione.
Norseth T; Alexander J; Aaseth J; Langård S
Acta Pharmacol Toxicol (Copenh); 1982 Nov; 51(5):450-5. PubMed ID: 7164826
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion and distribution of 51Cr(III) and 51Cr(VI) in rats.
Cikrt M; Bencko V
J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):241-6. PubMed ID: 575148
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice.
Kirpnick-Sobol Z; Reliene R; Schiestl RH
Cancer Res; 2006 Apr; 66(7):3480-4. PubMed ID: 16585171
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of vanadium(V) and chromium(III) on lipid peroxidation in liver and kidney of rats.
Scibior A; Zaporowska H; Ostrowski J; Banach A
Chem Biol Interact; 2006 Feb; 159(3):213-22. PubMed ID: 16387290
[TBL] [Abstract][Full Text] [Related]
18. Characterization of nonmutagenic Cr(III)-DNA interactions.
Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA synthesis by chromium compounds.
Nishio A; Uyeki EM
J Toxicol Environ Health; 1985; 15(2):237-44. PubMed ID: 3892022
[TBL] [Abstract][Full Text] [Related]
20. Pathways of Cr (III) and Cr (VI) in the rat after intratracheal administration.
Edel J; Sabbioni E
Hum Toxicol; 1985 Jul; 4(4):409-16. PubMed ID: 4018821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
